A whistleblower involved in the revelation that Texas Children’s Hospital (TCH) has continued to provide “gender-affirming care” to children has been visited by agents of the U.S. Department of Justice (DOJ).
Last year, a whistleblower report found that TCH had not complied with its own stated goal to end its practice of providing sex transition procedures to children.
Christopher Rufo, a senior fellow at the Manhattan Institute, published leaked documents that explained how puberty blockers and cross-sex hormone therapy were being provided to patients during puberty and early adolescence in addition to “gender-affirming surgeries.”
Also included were documents that describe an 11-year-old patient as a “female-to-male transgender person” and children from 11 to 15 years old diagnosed with “gender dysphoria” and administered an “insert non-biodegradable drug delivery implant.”
The TCH whistleblower recently revealed his identity in an interview with ...